Wake Forest licenses its proprietary technologies to industry. Browse our portfolio to find an opportunity to partner with us to develop our intellectual property into market-ready products.
Serious Pseudomonas infections usually occur in people in the hospital and/or with weakened immune systems. Infections of the blood, pneumonia,
The multi-compartmental therapy of glioblastoma and other aggressive malignancies uses therapeutic and imaging agents for the treatment, diagnosis and monitoring of these types of cancers.
These nicotinic acetylcholine receptor channel modulators show potential for smoking cessation with limited side effects in animal models.
KPC34 is an orally active, small molecule orphan disease therapeutic for the treatment of hematological cancers that overcomes resistance mechanisms common in leukemia.
These water soluble polymers are easily introduced into the body and generate heat when targeted with a laser, allowing them to destroy cancer cells and unwanted tissues.
Flagellin/F1/V is a flagellin-based vaccine that has demonstrated high effectiveness against pneumonic plague in primate and rodent models.
TCAng05 has dual cancer-fighting and cardiovascular-protective properties, making it a safe, effective biologic alternative to chemotherapy for the treatment of triple-negative breast cancer.
The Locking Ventilator Bag is a ventilator bag with a built-in, secure locking mechanism that ensures the ventilator bag is securely attached to a gas machine during anesthesia.
The single-prong nasal cannula is uniquely designed to deliver maximum oxygen and accurately monitor carbon dioxide levels while also reducing the risk of oxygen ignition.
Mechanical Tissue Resuscitation, designed for internal injuries, uses negative pressure to create an environment that fosters cell survival and tissue growth.
This simulation device features adjustable components that make it suitable for various levels of training for all ultrasound-guided invasive procedures.
The Suture Needle Cover secures needles during surgery, protecting medical professionals and patients from accidental percutaneous injury.
The Endotracheal Tube Exchanger safely facilitates the exchange of endotracheal tubes in critically ill patients by providing direct visualization and improving stabilization.
Clinical experts at Wake Forest have designed an improved Subdural Hematoma Port by adding a component to mechanically break-up clots that obstruct the port.
The multi-cancer panel provides an inexpensive and convenient personalized genetic report that outperforms family history as a predictor of risk.
The Cell Disk collects cell samples during fine needle aspirate patient biopsies, improving overall sample collection and the cytological and histological processing of biopsies.
Wake Forest’s Functional Assessment Instruments are inexpensive and convenient patient-centric tools to measure and track health-related outcomes in real time.
Using MRI image data, RenalVue electronically evaluates renal conditions and therapy impacts on kidneys more efficiently and effectively than conventional tools.
Blood-based mitochondrial bioenergetics profiling is a minimally invasive, inexpensive, high throughput, rapid blood-based test to measure and monitor mitochondrial bioenergetic
These novel compounds and chelation strategies detect tumors with better in vivo stability and production safety than current clinical standards.
This two-gene assay identifies breast cancer patients who are likely to achieve long-term survival with tamoxifen treatment alone.
An inexpensive, accurate and non-invasive one-step genetic test that screens for risk of prostate cancer.
The Demon Voltammetry software, written in LabView programming language, performs fast scan cyclic voltammetry recordings in brain tissue to detect neurotransmitters.
Organic electronic materials have the potential for general incorporation into consumer technologies. The materials are versatile and can be used